The Delaware Court of Chancery has rejected a lawsuit filed by BioClinica Inc.'s shareholders against the company, ruling that the company's board did not breach its fiduciary duties when it agreed to a $123 million buyout from JLL Partners Inc.
Glasscock Rejects Suit Over $123 Mil. Biotechnology Merger
Delaware Business Court Insider
October 23, 2013